Psychedelics like LSD and psilocybin (the active ingredient in magic mushrooms) are gaining increasing attention in psychiatry. Studies suggest they may offer therapeutic benefits for conditions such as depression, anxiety, obsessive–compulsive disorder, eating disorders and addiction.
Our research team is investigating whether N,N-dimethyltryptamine (DMT), a fast-acting psychedelic, can help people reduce alcohol consumption.
